BioSpace News Archive

Drug Development

Poxel and Sumitomo Dainippon Pharma Announce Initiation of Phase III Program for Imeglimin, an Investigational Therapeutic Agent for Type 2 Diabetes, in Japan

In December 2017, the first patient was included in the TIMES 1 trial, a multicenter, double-blind, placebo-controlled, randomized, monotherapy study in over 200 Japanese patients with type 2 diabetes.

December 27, 2017
·
7 min read
Policy

CStone Files MEK Inhibitor CS3006 for Clinical Trial Approval in Australia

Preliminary studies have shown that CS3006 demonstrated good pharmacokinetic properties, and has produced promising synergistic activity when combined with an anti-PD-1 antibody in animal models.

December 27, 2017
·
4 min read
Business

Astrotech Reports Final Results From Fiscal Year 2017 Annual Meeting of Shareholders

Astrotech reported the final results of its fiscal year 2017 Annual Meeting of Shareholders held on December 7, 2017 and reconvened on December 22, 2017.

December 27, 2017
·
2 min read
BioMidwest

Cincinnati Children’s Hospital Medical Center Study Explores Impact of Obesity on Bone Marrow Cells

New research published in the Journal of Experimental Medicine highlights the pernicious effect of obesity on the long-term health of blood-making stem cells.

December 27, 2017
·
2 min read
BioMidwest

Cellular Dynamics International Sends Human iPSC-Derived Cardiomyocytes To International Space Station On NASA Resupply Mission

The purpose of the scientific research project utilizing CDI’s iCell Cardiomyocytes in space is to validate the function of NASA’s new Bioculture System for automated cell culture on the International Space Station and to study human cardiac cell function in microgravity.

December 27, 2017
·
3 min read
Pharm Country

Up to 10 Percent Off for 2017 Christmas and the New Year From Creative BioMart

Creative BioMart recently launched its biggest promotion of the year 2017 to celebrate the coming Christmas and the New Year.

December 27, 2017
·
1 min read
Policy

Merus Announces the U.S. Court of Appeals for the Federal Circuit Denies Regeneron’s Petition to Rehear the Panel’s Decision Affirming Merus’ Inequitable Conduct Claim Against Regeneron

Regeneron filed the complaint against Merus alleging that it infringed one or more claims in the ‘018 patent in 2014.

December 27, 2017
·
6 min read
Policy

Protalix BioTherapeutics’ PRX-102 Granted Orphan Drug Designation by the European Commission

The decision by the Commission confirms the opinion previously issued by the EMA Committee for Orphan Medicinal Products.

December 27, 2017
·
4 min read